170 related articles for article (PubMed ID: 8534764)
1. Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL.
Böhme A; Ganser A; Hoelzer D
Ann Hematol; 1995 Dec; 71(6):311-2. PubMed ID: 8534764
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies.
Kamaluddin M; McNally P; Breatnach F; O'Marcaigh A; Webb D; O'Dell E; Scanlon P; Butler K; O'Meara A
Acta Paediatr; 2001 Oct; 90(10):1204-7. PubMed ID: 11697438
[TBL] [Abstract][Full Text] [Related]
3. Severe vincristine neurotoxicity with concomitant use of itraconazole.
Ariffin H; Omar KZ; Ang EL; Shekhar K
J Paediatr Child Health; 2003 Nov; 39(8):638-9. PubMed ID: 14629538
[No Abstract] [Full Text] [Related]
4. Itraconazole-related increased vincristine neurotoxicity: case report and review of literature.
Bermúdez M; Fuster JL; Llinares E; Galera A; Gonzalez C
J Pediatr Hematol Oncol; 2005 Jul; 27(7):389-92. PubMed ID: 16012330
[TBL] [Abstract][Full Text] [Related]
5. Posaconazole-increased vincristine neurotoxicity in a child: a case report.
Eiden C; Palenzuela G; Hillaire-Buys D; Margueritte G; Cociglio M; Hansel-Esteller S; Peyriere H
J Pediatr Hematol Oncol; 2009 Apr; 31(4):292-5. PubMed ID: 19346885
[TBL] [Abstract][Full Text] [Related]
6. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.
Jeng MR; Feusner J
Pediatr Hematol Oncol; 2001 Mar; 18(2):137-42. PubMed ID: 11255732
[TBL] [Abstract][Full Text] [Related]
7. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients.
Yasu T; Ohno N; Kawamata T; Kurokawa Y
Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157
[TBL] [Abstract][Full Text] [Related]
8. Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.
Yang L; Yu L; Chen X; Hu Y; Wang B
Med Sci Monit; 2015 Jun; 21():1656-61. PubMed ID: 26050202
[TBL] [Abstract][Full Text] [Related]
9. Severe vincristine toxicity in combination with itraconazole.
Gillies J; Hung KA; Fitzsimons E; Soutar R
Clin Lab Haematol; 1998 Apr; 20(2):123-4. PubMed ID: 9681224
[TBL] [Abstract][Full Text] [Related]
10. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Harnicar S; Adel N; Jurcic J
J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
[TBL] [Abstract][Full Text] [Related]
11. A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study.
Mokhtar GM; Shaaban SY; Elbarbary NS; Fayed WA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):594-600. PubMed ID: 20921909
[TBL] [Abstract][Full Text] [Related]
12. Vincristine neurotoxicity in the presence of hereditary neuropathy.
Trobaugh-Lotrario AD; Smith AA; Odom LF
Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
[No Abstract] [Full Text] [Related]
13. [Severe neurotoxicological reaction by combined treatment with vincristine and fluconazole].
Hellfritzsch M; Lassen P; Nielsen LP
Ugeskr Laeger; 2013 Apr; 175(15):1042-3. PubMed ID: 23582127
[TBL] [Abstract][Full Text] [Related]
14. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
[TBL] [Abstract][Full Text] [Related]
15. Itraconazole-enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia.
Chen S; Wu D; Sun A; Qiu H; Jin Z; Tang X; Miao M; Fu Z; Ma X; Han Y; Hu X
Am J Hematol; 2007 Oct; 82(10):942. PubMed ID: 17617780
[No Abstract] [Full Text] [Related]
16. Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine.
Jain S; Kapoor G
Pediatr Blood Cancer; 2010 May; 54(5):783. PubMed ID: 20205256
[No Abstract] [Full Text] [Related]
17. Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.
Moriyama B; Henning SA; Leung J; Falade-Nwulia O; Jarosinski P; Penzak SR; Walsh TJ
Mycoses; 2012 Jul; 55(4):290-7. PubMed ID: 22126626
[TBL] [Abstract][Full Text] [Related]
18. Risk of azole-enhanced vincristine neurotoxicity in pediatric patients with hematological malignancies: old problem - new dilemma.
Pana ZD; Roilides E
Pediatr Blood Cancer; 2011 Jul; 57(1):30-5. PubMed ID: 21265011
[TBL] [Abstract][Full Text] [Related]
19. Severe neurological disorders and refractory aspergillosis in an adolescent treated by vincristine and voriconazole.
Bennis Y; Bodeau S; Lutun A; Gourmel A; Solas C; Quaranta S; Guillaume N; Chouaki T; Lemaire-Hurtel AS; Masmoudi K
J Clin Pharm Ther; 2018 Apr; 43(2):265-268. PubMed ID: 28795412
[TBL] [Abstract][Full Text] [Related]
20. Enhanced vincristine neurotoxicity from drug interactions: case report and review of literature.
Sathiapalan RK; El-Solh H
Pediatr Hematol Oncol; 2001 Dec; 18(8):543-6. PubMed ID: 11764105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]